Envestnet Asset Management
RCKT icon

Envestnet Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Envestnet Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,286
Closed -$229K – 4534
2025
Q1 		$229K Buy
34,286
+1,864
+6% +$18.4K ﹤0.01% 4077
2024
Q4 		$408K Buy
32,422
+1,280
+4% +$19.3K ﹤0.01% 3703
2024
Q3 		$575K Buy
31,142
+1,351
+5% +$27.7K ﹤0.01% 3469
2024
Q2 		$641K Buy
29,791
+1,222
+4% +$28.1K ﹤0.01% 3313
2024
Q1 		$770K Sell
28,569
-2,182
-7% -$62K ﹤0.01% 3193
2023
Q4 		$922K Buy
30,751
+5,992
+24% +$132K ﹤0.01% 2990
2023
Q3 		$507K Buy
24,759
+7,315
+42% +$133K ﹤0.01% 3247
2023
Q2 		$347K Buy
17,444
+3,356
+24% +$67.8K ﹤0.01% 3414
2023
Q1 		$241K Buy
14,088
+1,048
+8% +$20.5K ﹤0.01% 3558
2022
Q4 		$255K Buy
+13,040
New +$240K ﹤0.01% 3536

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return